Intimation for approval of Employee Stock Option Scheme
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eyantra Ventures' Board approved standalone and consolidated un-audited financial results for the quarter ended June 30, 2025, along with limited review reports from the statutory auditor. The Board also approved the 'Eyantra Ventures Limited – Employee Stock Option Scheme 2025' to grant stock options of up to 2,00,000 (two lakh) shares to eligible employees and subsidiaries, subject to shareholder approval under SEBI's Share Based Employee Benefits Regulations, 2021. No grants have been made under the scheme yet, and exercise price will be tied to the previous preferential issue price or as decided by the Compensation Committee. Additionally, M/s. Vivek Surana & Associates was appointed as Secretarial Auditor for five years (40th to 45th AGM). The 40th Annual General Meeting is scheduled for September 30, 2025, via video conferencing.
The ESOP scheme will dilute existing shareholders by up to 2,00,000 shares if fully granted and exercised, but no immediate dilution since no grants have been made yet. The Q1 results filing shows the company is meeting its quarterly disclosure obligations on time, which is a routine positive compliance signal. No material red flags for shareholders based on this announcement.